Literature DB >> 17239676

Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure.

Kavitha M Chinnaiyan1, Daniel Alexander, Michael Maddens, Peter A McCullough.   

Abstract

Among the general heart failure (HF) population, over half have diastolic HF (DHF). The proportion of DHF increases with age, from 46% in patients younger than 45 years to 59% in patients older than 85 years. The diagnosis of DHF is made by the combination of signs and symptoms of HF with preserved systolic function (left ventricular ejection fraction >50%), and evidence of diastolic dysfunction obtained by echocardiographic Doppler examination, invasive hemodynamic evaluation, or an elevation of serum B-type natriuretic peptide. The most common risk factors for the development of diastolic dysfunction and DHF include long-standing hypertension, older age, female sex, obesity, diabetes, chronic kidney disease, and coronary artery disease. Acute decompensation occurs in the setting of pressure overload, volume overload, or superimposed cardiac ischemia. The cornerstones of in-hospital management include blood pressure and volume control, heart rate control, and correction of precipitating factors. Priorities in the outpatient clinic include optimal blood pressure control, maintenance of euvolemia with minimal or no diuretics, and, potentially, use of disease-modifying drugs including angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, aldosterone receptor blockers, beta-blockers, and digoxin. Long-term regression of left ventricular hypertrophy, improvement in diastolic filling parameters, and sustained reductions in B-type natriuretic peptide may be future treatment targets for this condition.

Entities:  

Mesh:

Year:  2007        PMID: 17239676     DOI: 10.1016/j.ahj.2006.10.022

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

1.  E/A ratio alone cannot reliably diagnose diastolic dysfunction in the assessment before and after TIPS.

Authors:  R D Abeles; D L Shawcross; G Auzinger
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

Review 2.  Cardiac magnetic resonance at high field: promises and problems.

Authors:  Ahmed M Gharib; Abdalla Elagha; Roderic I Pettigrew
Journal:  Curr Probl Diagn Radiol       Date:  2008 Mar-Apr

3.  Left ventricular diastolic dysfunction in bronchopulmonary dysplasia.

Authors:  Peter M Mourani; D Dunbar Ivy; Adam A Rosenberg; Thomas E Fagan; Steven H Abman
Journal:  J Pediatr       Date:  2008-02       Impact factor: 4.406

4.  The prognostic value of anemia in patients with diastolic heart failure.

Authors:  Faramarz Tehrani; Anita Phan; Ryan Morrissey; Christopher Chien; Asim Rafique; Ernst R Schwarz
Journal:  Tex Heart Inst J       Date:  2009

5.  Cardiorenal syndromes.

Authors:  Peter A McCullough; Aftab Ahmad
Journal:  World J Cardiol       Date:  2011-01-26

6.  Influence of myocardial ischemia on outcomes in patients with systolic versus non-systolic heart failure.

Authors:  Thomas E Vanhecke; Barry A Franklin; Prem Soman; Avijit Lahiri; Jennifer H Mieres; Tina Sias; Dennis A Calnon; David Wolinsky; James E Udelson; Peter A McCullough
Journal:  Am J Cardiovasc Dis       Date:  2011-07-27

7.  [Diastolic heart failure: heart failure with preserved ejection fraction].

Authors:  P Dovjak
Journal:  Z Gerontol Geriatr       Date:  2013-01       Impact factor: 1.281

Review 8.  Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?

Authors:  Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction.

Authors:  Hari K Parthasarathy; Burkert Pieske; Marianne Weisskopf; Chris D Andrews; Patrick Brunel; Allan D Struthers; Thomas M MacDonald
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

10.  Diastolic dysfunction and chronic kidney disease.

Authors:  Goo-Yeong Cho
Journal:  Korean J Intern Med       Date:  2012-12-28       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.